SECONDARY HYPERPARATHYROIDISM
Clinical trials for SECONDARY HYPERPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new SECONDARY HYPERPARATHYROIDISM trials appear
Sign up with your email to follow new studies for SECONDARY HYPERPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids on dialysis: drug targets overactive glands
Disease control Recruiting nowThis study tests a drug called etelcalcetide in children aged 28 days to under 18 years who have chronic kidney disease and are on dialysis. The goal is to see if the drug can safely lower high levels of parathyroid hormone, which can cause bone and heart problems. About 56 parti…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
New hope for kids on dialysis: drug targets overactive glands
Disease control Recruiting nowThis study tests a drug called etelcalcetide in 24 children aged 2 to 17 who have high parathyroid hormone levels due to kidney disease and are on hemodialysis. The goal is to see if the drug safely lowers these hormone levels. Participants will receive the drug during dialysis s…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 22, 2026 13:52 UTC